Enzon Pharmaceuticals, Inc.’s (ENZN) MACD indicator has moved into bearish territory with a reading of -0.0963. The Zacks #5 Rank (“Strong Sell”) stock decreased more than 1% to $10.69 in the morning trade. The Zacks Consensus Estimate on the company’s earnings for the year ending 2010 has decreased by 4 cents over the past week to 13 cents per share.
 
ENZON PHARMA (ENZN): Free Stock Analysis Report
 
Zacks Investment Research